Homepage
Medication Guide
Tazemetostat(TAZVERIK) provides a new treatment path for patients with multiple refractory and recurrent diseases
Tazemetostat(TAZVERIK) is a novel EZH2 inhibitor that provides a new treatment pathway for patients with multiple refractory and recurrent diseases. It blocks the growth and spread of lesion cell...
513
Friday, June 20th, 2025, 10:25
Tazemetostat's indications
Tazemetostat is a selective oral EZH2 (Enhancer of Zeste Homolog 2) inhibitor. EZH2 is an enzyme responsible for histone methylation in cells and has an important impact on cell proliferation and...
506
Friday, June 20th, 2025, 10:22
Side effects caused by Elacestrant
Elacestrant, the main component of Elacestrant, is mainly adapted to postmenopausal women or adult men with breast-related diseases. As a novel selective estrogen receptor degrader, it has shown signi...
507
Thursday, June 19th, 2025, 16:58
Side effects of Elacestrant
Elacestrant is a novel estrogen receptor antagonist that provides an important therapeutic option for specific breast cancer patients. However, similar to other drugs, a series of side effects may occ...
505
Thursday, June 19th, 2025, 16:22
What is the therapeutic effect of Elacestrant?
Elacestrant was developed and produced by Stemline, the United States, and was approved by the U.S. Food and Drug Administration (FDA) in January 2023, becoming the only oral selective estrogen recept...
509
Thursday, June 19th, 2025, 16:16
How effective is Elacestrant?
In the treatment of breast diseases, the emergence of Elacestrant is of great significance. As an oral SERD, it is able to directly degrade estrogen receptors, thereby inhibiting the growth of disease...
506
Thursday, June 19th, 2025, 16:08
Is Elacestrant(ORSERDU) effective?
The launch of the breast disease treatment drug ORSERDU/Elacestrant has brought new vitality to countless patients. This drug selectively degrades estrogen receptors and effectively blocks the growth ...
508
Thursday, June 19th, 2025, 15:24
Guidelines for the use of Elacestrant
Elacestrant(Orserdu) is a novel estrogen receptor antagonist for patients with specific types of breast cancer. This article will systematically explain the key information of the drug from three aspe...
508
Thursday, June 19th, 2025, 15:18
How to use Elacestrant?
Elacestrant is a novel estrogen receptor antagonist suitable for patients with specific types of advanced breast cancer. Correct use of this drug can not only improve the efficacy, but also reduce the...
503
Thursday, June 19th, 2025, 15:12
Dosage and Administration of Elacestrant(Orserdu)
Elacestrant(Orserdu) is a novel estrogen receptor antagonist designed for patients with ER-positive, HER2-negative advanced or metastatic breast cancer harboring ESR1 mutations. It inhibits the growth...
506
Thursday, June 19th, 2025, 15:06
204 / 208
2075 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved